Correlation Between Adocia and Innate Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Adocia and Innate Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Adocia and Innate Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Adocia and Innate Pharma, you can compare the effects of market volatilities on Adocia and Innate Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Adocia with a short position of Innate Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Adocia and Innate Pharma.

Diversification Opportunities for Adocia and Innate Pharma

-0.43
  Correlation Coefficient

Very good diversification

The 3 months correlation between Adocia and Innate is -0.43. Overlapping area represents the amount of risk that can be diversified away by holding Adocia and Innate Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Innate Pharma and Adocia is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Adocia are associated (or correlated) with Innate Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Innate Pharma has no effect on the direction of Adocia i.e., Adocia and Innate Pharma go up and down completely randomly.

Pair Corralation between Adocia and Innate Pharma

Assuming the 90 days trading horizon Adocia is expected to under-perform the Innate Pharma. In addition to that, Adocia is 1.25 times more volatile than Innate Pharma. It trades about -0.19 of its total potential returns per unit of risk. Innate Pharma is currently generating about -0.01 per unit of volatility. If you would invest  194.00  in Innate Pharma on December 30, 2024 and sell it today you would lose (8.00) from holding Innate Pharma or give up 4.12% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Adocia  vs.  Innate Pharma

 Performance 
       Timeline  
Adocia 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Adocia has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Innate Pharma 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Innate Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong technical indicators, Innate Pharma is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Adocia and Innate Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Adocia and Innate Pharma

The main advantage of trading using opposite Adocia and Innate Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Adocia position performs unexpectedly, Innate Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Innate Pharma will offset losses from the drop in Innate Pharma's long position.
The idea behind Adocia and Innate Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.

Other Complementary Tools

Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
CEOs Directory
Screen CEOs from public companies around the world
Fundamental Analysis
View fundamental data based on most recent published financial statements